Axa’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.5M | Buy |
175,632
+282
| +0.2% | +$8.83K | 0.02% | 544 |
|
|
2025
Q1 | $5.88M | Sell |
175,350
-12,446
| -7% | -$418K | 0.02% | 507 |
|
|
2024
Q4 | $7.36M | Sell |
187,796
-294
| -0.2% | -$11.5K | 0.02% | 445 |
|
|
2024
Q3 | $7.41M | Buy |
188,090
+52
| +0% | +$2.05K | 0.02% | 453 |
|
|
2024
Q2 | $7.33M | Buy |
188,038
+166
| +0.1% | +$6.47K | 0.02% | 453 |
|
|
2024
Q1 | $8.09M | Buy |
187,872
+51
| +0% | +$2.2K | 0.02% | 449 |
|
|
2023
Q4 | $8.65M | Sell |
187,821
-4,542
| -2% | -$209K | 0.03% | 427 |
|
|
2023
Q3 | $6.57M | Sell |
192,363
-672
| -0.3% | -$23K | 0.02% | 478 |
|
|
2023
Q2 | $7.43M | Buy |
193,035
+2,655
| +1% | +$102K | 0.02% | 470 |
|
|
2023
Q1 | $6.81M | Sell |
190,380
-414
| -0.2% | -$14.8K | 0.02% | 487 |
|
|
2022
Q4 | $7.52M | Sell |
190,794
-1,042
| -0.5% | -$41.1K | 0.03% | 502 |
|
|
2022
Q3 | $6.93M | Buy |
191,836
+485
| +0.3% | +$17.5K | 0.03% | 510 |
|
|
2022
Q2 | $5.82M | Sell |
191,351
-3,701
| -2% | -$113K | 0.02% | 542 |
|
|
2022
Q1 | $5.96M | Buy |
195,052
+4
| +0% | +$122 | 0.02% | 601 |
|
|
2021
Q4 | $6.09M | Buy |
195,048
+35,405
| +22% | +$1.11M | 0.02% | 615 |
|
|
2021
Q3 | $2.44M | Buy |
+159,643
| New | +$2.44M | 0.01% | 820 |
|